India’s bioinformatics sector is expanding rapidly, driven by increasing genomic data generation and demand for precision medicine.¹
India’s bioinformatics ecosystem is undergoing a steady transformation. While established companies like Strand Life Sciences and MedGenome remain widely recognized, a group of lesser-known startups is contributing to advances in genomics, data analysis, and computational biology.
These companies operate largely in research-driven and enterprise-focused environments, which limits their public visibility. However, their work supports diagnostics, drug discovery, and precision medicine, making them important contributors to India’s life sciences ecosystem.
India’s bioinformatics market is expanding due to increasing demand for genomic analysis, integration of artificial intelligence, and the growth of data-intensive healthcare systems.
According to IMARC Group, the Indian bioinformatics market reached USD 577.1 million in 2025 and is projected to reach USD 2,645.6 million by 2034, growing at a CAGR of 17.88 percent from 2026 to 2034.¹
Similarly, Grand View Research reports that the bioinformatics services market in India was valued at USD 121.1 million in 2024 and is expected to reach USD 275.8 million by 2030, with next-generation sequencing emerging as the dominant segment.²
This growth is driven by increasing use of cloud computing, big data analytics, and the rising volume of genomic datasets.¹
Bioinformatics in India is largely driven by technologies such as next-generation sequencing, whole genome and exome sequencing, cloud-based data analysis platforms, and machine learning models for biological data interpretation.¹ ²
Next-generation sequencing represents one of the largest segments within bioinformatics services in India due to its widespread use in genomics research and diagnostics.²
Key end users of bioinformatics services in India include pharmaceutical and biotechnology companies, academic and research institutes, as well as hospitals and diagnostic laboratories.¹ ²
Advances in sequencing technologies and computational tools have contributed to a gradual reduction in the cost of genomic analysis, improving accessibility in India.¹
Underrated bioinformatics startups in India typically share certain characteristics:
They operate in specialized areas such as genomics, transcriptomics, and infectious disease analytics
Their services are primarily business-to-business or research-oriented
They develop analytical platforms, pipelines, or infrastructure rather than direct consumer products
Many have expanded after 2020, aligning with increased genomic research activity
These factors contribute to lower visibility despite technical relevance.
Elucidata develops data-centric platforms for life sciences research. Its platform focuses on structuring, standardizing, and harmonizing biomedical datasets to make them usable for downstream analysis. The company’s cloud-based platform Polly enables integration of multi-omics, clinical, and imaging data into a unified system, supporting applications such as biomarker discovery, patient stratification, and target identification.
A key feature of Elucidata’s approach is its emphasis on AI-ready data, where datasets are curated, annotated, and harmonized to improve machine learning performance in drug discovery and precision medicine workflows.
Clevergene provides end-to-end genomics and bioinformatics services, including sequencing, analysis, and interpretation. The company offers a wide range of sequencing capabilities such as genome sequencing, epigenome sequencing, metagenome sequencing, RNA sequencing, and single-cell expression analysis, enabling detailed molecular insights.
Its workflows are designed to identify genetic variants, study gene expression, and analyze epigenetic changes, supporting applications across clinical diagnostics, research, and precision medicine.
BioNome focuses on genetic testing and genomic interpretation with an emphasis on clinical applications. The company has developed internal infrastructure for handling large-scale genomic datasets and delivering diagnostic insights, supported by its bioinformatics pipelines.
Its portfolio reflects a focus on personalized healthcare and clinical genomics, where genomic data is translated into actionable clinical information.
HaystackAnalytics applies genomics and bioinformatics to infectious diseases, with a strong focus on rapid diagnostics. Its Universal Infectious Diseases Test is an NGS-based, culture-free test capable of identifying over 1200 pathogens and detecting antibiotic resistance genes.
The platform provides results in under 12 hours, significantly reducing turnaround time compared to traditional culture-based methods.
D-NOME provides genomics and bioinformatics services, including sequencing and downstream data analysis. The company focuses on enabling data-driven insights from genomic datasets for research and diagnostic applications.
D-NOME is involved in training and capacity building initiatives in genomics and bioinformatics, contributing to workforce development alongside its service offerings.
ArrayGen Technologies delivers next-generation sequencing services integrated with bioinformatics analysis. Its offerings include genome sequencing, transcriptomics, metagenomics, and data interpretation, supporting research across multiple domains.
The company provides end-to-end sequencing workflows, from data generation to analysis, which is essential for academic and industrial research.
Zifo RnD Solutions provides informatics and data management solutions for research and development environments. Its services include laboratory informatics, data integration, and workflow digitization, enabling organizations to manage complex scientific data systems.
Zifo’s work focuses on improving data accessibility, interoperability, and digital transformation in research environments.
Bioinformatics applications in India include genomic sequencing and analysis, drug discovery and development, clinical diagnostics and precision medicine, and proteomics and transcriptomics research.¹²
Bioinformatics is increasingly being integrated into clinical workflows, particularly in oncology, rare disease diagnosis, and pharmacogenomics.¹
Companies such as Elucidata focus on structuring and managing biological data, enabling AI-driven insights and improving research efficiency.
Clevergene and BioNome apply sequencing technologies and bioinformatics pipelines to clinical diagnostics, including rare diseases and genetic conditions.
HaystackAnalytics demonstrates the application of genomics in rapid pathogen detection and antibiotic resistance profiling.
ArrayGen Technologies and Zifo RnD Solutions support research and industry by providing sequencing, analytics, and data management systems.
These companies contribute to:
Development of infrastructure for genomic data analysis
Expansion of sequencing and analytical capabilities in India
Creation of India-specific biological datasets
Support for precision medicine and data-driven diagnostics
Bioinformatics plays a central role in analyzing complex biological datasets such as DNA sequences, protein structures, and gene expression profiles, which are critical for modern biomedical research.¹
One of the major challenges in bioinformatics is the management and interpretation of large-scale biological data, which requires advanced computational infrastructure and standardized data pipelines.¹
The growth of bioinformatics in India is expected to continue due to increasing adoption of sequencing technologies and computational tools.
India offers advantages such as a large and genetically diverse population, growing sequencing infrastructure, and increasing collaboration between academia and industry.¹
The growth of bioinformatics startups is supported by a multidisciplinary workforce combining biology, computer science, and data analytics expertise.¹
Key areas of focus include:
Rare disease genomics
Multi-omics data integration
AI-based drug discovery
Clinical decision support systems
Microbiome and metagenomics research
Multi-omics approaches integrate genomics, proteomics, and metabolomics data to provide a more comprehensive understanding of disease biology.
The growth of genomics and bioinformatics also raises considerations around data privacy, ethical use of genetic information, and regulatory oversight, especially in clinical applications.
Underrated bioinformatics startups in India are contributing to core scientific and clinical advancements without significant public visibility. Their work in genomics, data analysis, and informatics supports broader developments in healthcare, research, and pharmaceuticals. As the ecosystem grows, these companies are positioned to play an important role in managing and interpreting biological data at scale.
As genomic data continues to expand, these startups are likely to play a central role in shaping data-driven healthcare in India.
IMARC Group. India Bioinformatics Market.
https://www.imarcgroup.com/india-bioinformatics-market
Grand View Research. India Bioinformatics Services Market.
https://www.grandviewresearch.com/horizon/outlook/bioinformatics-services-market/india
